Annual report pursuant to Section 13 and 15(d)

Statement of Cash Flows

v3.8.0.1
Statement of Cash Flows - USD ($)
 12 Months Ended
Nov. 30, 2017
Nov. 30, 2016
Cash Flows from Operating Activities    
Net loss $ (307,274) $ (90,189)
Changes in operating assets and liabilities    
Decrease (increase) in prepaid expenses 15,350 (32,219)
Increase in accounts payable 100,181 24,750
Increase (decrease) in accrued liabilities (13,000) 25,500
Net cash used in operating activities (204,743) (72,158)
Net cash used in Investing Activities,    
Cash deposited in Trust Account (604,300) (70,386,222)
Interest income earned on Trust Account (554,954) (56,393)
Interest withdrawn from Trust Account 386,014
Net cash used in investing activities (773,240) (70,442,615)
Cash Flows from Financing Activities    
Proceeds from sale of Sponsors' shares of common stock 25,000
Proceeds from sale of Public Offering Units, net of offering expenses paid 66,995,417
Proceeds from sale of Private Placement Warrants 3,985,244
Payments to related parties (including loans) (250,535)
Funds from related parties (including loans) 604,300 250,535
Net cash provided by financing activities 604,300 71,005,661
Net (decrease)/increase in cash (373,683) 490,888
Cash at beginning of period 490,888
Cash at end of period 117,205 490,888
Supplemental disclosure of non-cash investing and financing activities    
Deferred underwriting fees 1,725,153
Common stock issued for additional underwriter compensation 1,061,640
Fair value of unit purchase option issued to underwriter 781,385
Interest contributed for extension $ 200,772